Frank Nocken

Title: Frank Nocken: Innovator in Biochemical Detection and Therapeutics

Introduction

Frank Nocken is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of biochemical detection and therapeutics, holding 2 patents that showcase his innovative approaches.

Latest Patents

One of his latest patents focuses on the detection of starch levels in biological matrices. This invention provides methods for detecting starch in a sample, which includes incubating the sample in the presence of an amylase-containing medium. The sample is then subjected to liquid chromatography mass spectrometry (LC-MS) to detect ions characteristic of starch. The amylase-containing medium can consist of an amylase combined with blood plasma or a mixture of water, protein, salt, and organic substances. The incubating step is designed to allow the digestion of starch by the amylase.

Another significant patent relates to methods for increasing the effectiveness of antibodies and Fcγ receptor-binding active ingredients. This ex vivo method involves preparing a blood sample from a patient, subjecting it to immunoapheresis, and then administering a therapeutically effective antibody or Fcγ receptor-binding active ingredient to the patient.

Career Highlights

Frank Nocken has worked with prominent companies in the healthcare sector, including Fresenius Kabi Deutschland GmbH and Fresenius Medical Care Deutschland GmbH. His work in these organizations has contributed to advancements in medical technologies and therapeutic methods.

Collaborations

Throughout his career, Frank has collaborated with notable colleagues such as Silke Baasner and Klaus Biemel. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

Frank Nocken's innovative patents and career in the healthcare industry highlight his commitment to advancing biochemical detection and therapeutic methods. His contributions continue to impact the field positively.